25 Years
Here for Cancer Care
Here for Cancer Care
From diagnosis through survivorship, we deliver personalized therapies backed by precision medicine and coordinated treatment planning. Our cancer experts work together so that every patient receives the highest standard of specialized expertise.
Clinical trials bring options - and results
Linda jacobs of DeWitt, Iowa, has faced a cancer diagnosis three times in the past decade. She had a lumpetcomy in 2015 to remove a breast tumor only to have a different type of cancer develop in her other breast a few years later.
At that point, she opted for a double mastectomy and radiation treatments. But in 2021, she developed radiation-induced angiosarcoma, a cancer that forms in the lining of the blood and lymph vessels. She took an immunotherapy drug called Keytruda, which kept the cancer at bay - until it didn't.
Holden Comprehensive Cancer Center
By the numbers.
Cancer therapy closer to home
Every other week, Ron Fisher makes the one-hour trip from his home in Marshalltown, Iowa, to Mission Cancer + Blood, part of UI Health Care, to receive treatment for non-Hodgkin lymphoma.
“I walk in. I get my blood checked, and sometimes they’ll take a scan. I get a shot in the tummy area, and I go home until the next time. It takes about 15 minutes. And that’s it,” he says.
Fisher is a longtime cancer survivor — he was first diagnosed and treated in 1994 — whose lymphoma has returned several times over the years. The drug he currently receives is a relatively new treatment known as a bispecific antibody. It links healthy T cells to cancerous B cells to fight the cancer. It’s one of many T cell-mediated therapies available at Mission Cancer + Blood.
HERE FOR IOWA
University of Iowa Health Care's Annual Report